JP2013518086A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013518086A5 JP2013518086A5 JP2012550464A JP2012550464A JP2013518086A5 JP 2013518086 A5 JP2013518086 A5 JP 2013518086A5 JP 2012550464 A JP2012550464 A JP 2012550464A JP 2012550464 A JP2012550464 A JP 2012550464A JP 2013518086 A5 JP2013518086 A5 JP 2013518086A5
- Authority
- JP
- Japan
- Prior art keywords
- radioimmunoconjugate
- monoclonal antibody
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29952410P | 2010-01-29 | 2010-01-29 | |
| NO20100143A NO331080B1 (no) | 2010-01-29 | 2010-01-29 | Radioimmunkonjugater, farmasøytiske sammensetninger og kit omfattende det samme og anvendelse derav |
| NO20100143 | 2010-01-29 | ||
| US61/299,524 | 2010-01-29 | ||
| PCT/EP2011/051231 WO2011092295A2 (en) | 2010-01-29 | 2011-01-28 | Novel radioimmunoconjugates and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014225005A Division JP5855209B2 (ja) | 2010-01-29 | 2014-11-05 | 放射免疫コンジュゲートおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013518086A JP2013518086A (ja) | 2013-05-20 |
| JP2013518086A5 true JP2013518086A5 (enExample) | 2014-04-03 |
| JP5646652B2 JP5646652B2 (ja) | 2014-12-24 |
Family
ID=44319900
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012550464A Expired - Fee Related JP5646652B2 (ja) | 2010-01-29 | 2011-01-28 | 放射免疫コンジュゲートおよびその使用 |
| JP2014225005A Active JP5855209B2 (ja) | 2010-01-29 | 2014-11-05 | 放射免疫コンジュゲートおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014225005A Active JP5855209B2 (ja) | 2010-01-29 | 2014-11-05 | 放射免疫コンジュゲートおよびその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US8628749B2 (enExample) |
| EP (2) | EP2528627B1 (enExample) |
| JP (2) | JP5646652B2 (enExample) |
| KR (2) | KR101758409B1 (enExample) |
| CN (2) | CN104338154B (enExample) |
| AU (1) | AU2011209441B2 (enExample) |
| BR (1) | BR112012018843B8 (enExample) |
| CA (1) | CA2786655C (enExample) |
| DK (2) | DK2705857T3 (enExample) |
| ES (2) | ES2592402T3 (enExample) |
| HR (1) | HRP20140538T1 (enExample) |
| IL (2) | IL221091A (enExample) |
| MX (2) | MX2012008695A (enExample) |
| NO (1) | NO331080B1 (enExample) |
| NZ (1) | NZ601055A (enExample) |
| PH (2) | PH12012501516A1 (enExample) |
| PL (1) | PL2528627T3 (enExample) |
| PT (1) | PT2528627E (enExample) |
| RS (1) | RS53346B (enExample) |
| RU (2) | RU2560587C9 (enExample) |
| SG (1) | SG182685A1 (enExample) |
| SI (1) | SI2528627T1 (enExample) |
| UA (1) | UA108631C2 (enExample) |
| WO (1) | WO2011092295A2 (enExample) |
| ZA (1) | ZA201205007B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3272364B1 (en) * | 2011-12-13 | 2020-07-29 | Nordic Nanovector ASA | Chimeric therapeutic anti-cd37 antibodie hh1 |
| RU2014140119A (ru) * | 2012-03-30 | 2016-05-27 | Иммьюноджен, Инк. | Способы повышения эффективности терапии на основе cd37 |
| CN103933575B (zh) * | 2013-01-23 | 2017-09-29 | 上海新理念生物医药科技有限公司 | 一种三齿型连接子及其应用 |
| BR112015030457A2 (pt) * | 2013-06-07 | 2017-08-22 | Nordic Nanovector As | Método para regular positivamente a expressão de antígeno |
| AR097161A1 (es) * | 2013-08-01 | 2016-02-24 | Agensys Inc | Conjugados de fármacos anticuerpo (adc) que se unen a las proteínas cd37 |
| HK1250646A1 (zh) * | 2015-04-07 | 2019-01-11 | Memorial Sloan Kettering Cancer Center | 纳米粒子免疫偶联物 |
| GB201600328D0 (en) * | 2016-01-08 | 2016-02-24 | Univ Oslo Hf | Anti-CD37 chimeric antigen receptors and immune cells expressing them |
| SG11201901672RA (en) * | 2016-09-16 | 2019-03-28 | Nordic Nanovector Asa | Treatment of non-hodgkin lymphoma using lilotomab and 177lu-lilotomab satetraxetan |
| KR102406510B1 (ko) | 2017-07-03 | 2022-06-10 | 현대자동차주식회사 | 연료전지 시스템용 수소 공급 방법 |
| CN109550061A (zh) * | 2017-09-26 | 2019-04-02 | 南京江原安迪科正电子研究发展有限公司 | 一种用于放射性核素标记抗体的试剂盒及应用 |
| CN111372613A (zh) * | 2017-11-22 | 2020-07-03 | 诺帝克纳诺维科特公司 | 放射免疫缀合物与其他药物联合治疗非霍奇金淋巴瘤 |
| WO2020216947A1 (en) | 2019-04-24 | 2020-10-29 | Heidelberg Pharma Research Gmbh | Amatoxin antibody-drug conjugates and uses thereof |
| EP3958879A4 (en) * | 2019-04-25 | 2023-05-10 | Actinium Pharmaceuticals, Inc. | Compositions and methods of immunodepletion for the treatment of malignant and non-malignant hematological diseases |
| MX2023011031A (es) * | 2021-03-19 | 2023-12-14 | Heidelberg Pharma Res Gmbh | Conjugados de amatoxina y anticuerpo especificos de linfocitos b. |
| WO2023057595A1 (en) | 2021-10-06 | 2023-04-13 | Nordic Nanovector Asa | Humanized hh1 rew |
| US20250333531A1 (en) | 2021-10-06 | 2025-10-30 | Nordic Nanovector Asa | Humanized hh1 |
| CN114081969A (zh) * | 2021-11-23 | 2022-02-25 | 成都纽瑞特医疗科技股份有限公司 | 标记的小分子抗体、及其标记方法和应用 |
| CN117285631A (zh) * | 2023-11-24 | 2023-12-26 | 原子高科股份有限公司 | 用于放射性免疫治疗的Lu-177标记MUC1抗体 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595721A (en) * | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
| US20020028178A1 (en) * | 2000-07-12 | 2002-03-07 | Nabil Hanna | Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications |
| WO2001080884A1 (en) * | 2000-04-25 | 2001-11-01 | Idec Pharmaceuticals Corporation | Intrathecal administration of rituximab for treatment of central nervous system lymphomas |
| CA2509103A1 (en) * | 2002-12-13 | 2004-07-01 | Mitra Medical Technology Ab | Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| US7534427B2 (en) * | 2002-12-31 | 2009-05-19 | Immunomedics, Inc. | Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| JP4874090B2 (ja) * | 2003-01-31 | 2012-02-08 | イミューノメディクス、インコーポレイテッド | 治療薬および診断薬を投与するための方法および組成物 |
| JP4912153B2 (ja) * | 2003-12-01 | 2012-04-11 | イミューノメディクス、インコーポレイテッド | タンパク質とキレート剤とのコンジュゲートを調製するための改良された方法 |
| AU2006272555B2 (en) * | 2005-07-25 | 2012-03-08 | Aptevo Research And Development Llc | B-cell reduction using CD37-specific and CD20-specific binding molecules |
| PE20090499A1 (es) | 2007-08-09 | 2009-05-18 | Boehringer Ingelheim Int | Anticuerpos anti-cd37 |
-
2010
- 2010-01-29 NO NO20100143A patent/NO331080B1/no not_active IP Right Cessation
-
2011
- 2011-01-28 CA CA2786655A patent/CA2786655C/en active Active
- 2011-01-28 KR KR1020127020917A patent/KR101758409B1/ko not_active Expired - Fee Related
- 2011-01-28 MX MX2012008695A patent/MX2012008695A/es active IP Right Grant
- 2011-01-28 RU RU2012135430/10A patent/RU2560587C9/ru active
- 2011-01-28 HR HRP20140538AT patent/HRP20140538T1/hr unknown
- 2011-01-28 RU RU2015127407A patent/RU2664475C1/ru active
- 2011-01-28 PH PH1/2012/501516A patent/PH12012501516A1/en unknown
- 2011-01-28 MX MX2015000391A patent/MX342539B/es unknown
- 2011-01-28 UA UAA201208485A patent/UA108631C2/ru unknown
- 2011-01-28 RS RS20140300A patent/RS53346B/sr unknown
- 2011-01-28 US US13/522,678 patent/US8628749B2/en active Active
- 2011-01-28 PT PT117009720T patent/PT2528627E/pt unknown
- 2011-01-28 ES ES13195682.3T patent/ES2592402T3/es active Active
- 2011-01-28 JP JP2012550464A patent/JP5646652B2/ja not_active Expired - Fee Related
- 2011-01-28 EP EP11700972.0A patent/EP2528627B1/en not_active Not-in-force
- 2011-01-28 DK DK13195682.3T patent/DK2705857T3/en active
- 2011-01-28 CN CN201410353070.5A patent/CN104338154B/zh active Active
- 2011-01-28 KR KR1020177018914A patent/KR101893720B1/ko not_active Expired - Fee Related
- 2011-01-28 WO PCT/EP2011/051231 patent/WO2011092295A2/en not_active Ceased
- 2011-01-28 CN CN201180007272.9A patent/CN102762230B/zh not_active Expired - Fee Related
- 2011-01-28 ES ES11700972.0T patent/ES2469140T3/es active Active
- 2011-01-28 SG SG2012054607A patent/SG182685A1/en unknown
- 2011-01-28 PL PL11700972T patent/PL2528627T3/pl unknown
- 2011-01-28 NZ NZ601055A patent/NZ601055A/en not_active IP Right Cessation
- 2011-01-28 DK DK11700972.0T patent/DK2528627T3/da active
- 2011-01-28 BR BR112012018843A patent/BR112012018843B8/pt not_active IP Right Cessation
- 2011-01-28 EP EP13195682.3A patent/EP2705857B1/en active Active
- 2011-01-28 AU AU2011209441A patent/AU2011209441B2/en not_active Ceased
- 2011-01-28 SI SI201130157T patent/SI2528627T1/sl unknown
-
2012
- 2012-07-04 ZA ZA2012/05007A patent/ZA201205007B/en unknown
- 2012-07-24 IL IL221091A patent/IL221091A/en active IP Right Grant
-
2013
- 2013-12-09 US US14/100,756 patent/US9358309B2/en active Active
-
2014
- 2014-11-05 JP JP2014225005A patent/JP5855209B2/ja active Active
-
2015
- 2015-03-02 IL IL237507A patent/IL237507A0/en active IP Right Grant
-
2017
- 2017-06-05 PH PH12017501038A patent/PH12017501038B1/en unknown